Display Settings:

Format

Send to:

Choose Destination

    Am J Trop Med Hyg. 2008 Aug;79(2):239-44.

    Rapid suppression of Onchocerca volvulus transmission in two communities of the Southern Chiapas focus, Mexico, achieved by quarterly treatments with Mectizan.

    Rodríguez-Pérez MA, Lutzow-Steiner MA, Segura-Cabrera A, Lizarazo-Ortega C, Domínguez-Vázquez A, Sauerbrey M, Richards F Jr, Unnasch TR, Hassan HK, Hernández-Hernández R.

    Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Blvd. del Maestro esq. Elias Piña, Cd. Reynosa, Tamaulipas, Mexico. mrodriguez@ipn.mx

    The impact of quarterly Mectizan (ivermectin) treatments on transmission, microfiladermia, and ocular lesions was evaluated in two formerly hyperendemic communities (Las Golondrinas and Las Nubes II) located in the main endemic focus for onchocerciasis in Southern Chiapas, Mexico. The data suggest that Onchocerca volvulus transmission has been suppressed after elimination of microfiladermia in these two communities. Increasing the frequency of Mectizan treatment to four times per year appears to have resulted in the rapid suppression of transmission in communities with residual transmission.

    PMID: 18689630 [PubMed - indexed for MEDLINE]

    PMCID: PMC2570542

    Supplemental Content

    Click here to read Click here to read

    Patient drug information

    • Ivermectin (Stromectol®)

      Ivermectin is used to treat strongyloidiasis (threadworm; infection with a type of roundworm that enters the body through the skin, moves through the airways and lives in the intestines). Ivermectin is also used to contr...